参考文献/References:
[1]Imbert-Masseau A,Hamidou M,Agard C,et al.Antisynthetase syndrome[J].Joint Bone Spine,2003,70(3):161-168.[2]Ascherman D.Characterization of Jo1 specific T cell proliferative responses in polymyositis[J].Arthritis Rheum,2001(S263):1262．[3]Marie I,Josse S,Hatron PY,et al.Interstitial lung disease in antiJo-1 patients with antisynthetase syndrome[J].Arthritis Care Res(Hoboken),2013,65(5):800-808.[4]高扬,李国勤,王海隆,等.以肺部症状为首发表现的抗合成酶抗体综合征合并干燥综合征1例并文献复习[J].临床肺科杂志,2017,22(11):1993-1997.[5]Yoshifuji H,Fujii T,Kobayashi S,et al.Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies[J].Autoimmunity,2006,39(3):233-241.[6]Cavagna L,Nu?o L,Scirè CA,et al.Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study[J].Medicine (Baltimore),2015,94(32):e1144.[7]Johnston G.Antisynthetase syndrome[J].Clin Med (Lond),2017,17(6):591.[8]Kim SH,Park IN.Acute Respiratory Distress Syndrome as the Initial Clinical Manifestation of an Antisynthetase Syndrome[J].Tuberc Respir Dis (Seoul),2016,79(3):188-192.[9]Devi HG,Pasha MM,Padmaja MS,et al.Antisynthetase Syndrome: A Rare Cause for ILD[J].J Clin Diagn Res,2016,10(3):OD08-OD9.[10]Yoshifuji H,Fujii T,Kobayashi S,et al.Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies[J].Autoimmunity,2006,39(3):233-241.[11]Beaumel A,Muis-Pistor O,Tebib JG,et al.Antisynthetase syndrome treated with tocilizumab[J].Joint Bone Spine,2016,83(3):361-362．[12]苏垠旭,龚婕宁.从叶天士“初病在经，久病入络”理论论治肺纤维化[J].世界科学技术-中医药现代化,2015,17(6):1280-1284．[13]武维屏.武维屏学术思想及临床经验集[M].北京:中国中医药出版社,2014:82-97．[14]张天嵩,吴银根.通补肺络法治疗肺纤维化理论探讨[J].中医杂志,2002,43(11):808-810．
相似文献/References:
[1]周红恩,舒 婷,杜毅鹏,等.以肺部症状为首发的2例抗合成酶综合征报道[J].医学信息,2021,34(07):191.[doi:10.3969/j.issn.1006-1959.2021.07.057]
[2]孙瑞希,付 萍.抗MDA5抗体相关性皮肌炎的临床、实验室表现及治疗研究[J].医学信息,2021,34(08):31.[doi:10.3969/j.issn.1006-1959.2021.08.009]
SUN Rui-xi,FU Ping.Clinical and Laboratory Manifestations and Treatment of Anti-MDA5 Antibody-related Dermatomyositis[J].Medical Information,2021,34(12):31.[doi:10.3969/j.issn.1006-1959.2021.08.009]